HSE University researchers Evgeny Osin and Irina Turilina conducted an
Using AI to assess surgical performance
A research team at Inselspital, Bern University Hospital and Caresyntax
New self-administered digital health tool helps women assess risk for premature delivery
Women who are intending to become pregnant or who have
NBA players to assess new coronavirus test
(HealthDay)—A saliva-based test for the new coronavirus will be assessed
Lethargic global response to COVID-19: How the human brain’s failure to assess abstract threats cost us dearly
More U.S. citizens have confirmed COVID-19 infections than the next
Noninvasive technique to assess brain tumors in children and make treatment less toxic
Ground-breaking research by the University of Birmingham has discovered a
Breast cancer study confirms importance of multigenerational family data to assess risk
A team of researchers led by Columbia University Mailman School
Deciphera Pharmaceuticals Initiates a Phase 1b/2 Clinical Trial of Rebastinib in Combination with Paclitaxel to Assess Safety, Tolerability, Pharmacokinetics and Efficacy in Patients with Advanced or Metastatic Solid Tumors
WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 23, 2018– Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a